Fasting and postprandial lipid response to the consumption of modified milk fats by guinea pigs.
The objective of the present study was to investigate the effect of three modified milk fats with different melting profiles on fasting and postprandial lipid responses and on fecal fat content in guinea pigs. We hypothesized that the consumption of modified milk fat with a high m.p. results in reduced fasting and postprandial lipid responses compared with that of modified milk fat fractions with lower m.p. To test this hypothesis, male Hartley guinea pigs were fed isoenergetic diets containing 110 g of fat/kg, either from one of the three modified milk fats with high (HMF), medium (MMF), or low melting profiles (LMF), or from one of the two reference fats as whole milk fat (MF) or a fat blend similar to that of nonhydrogenated soft margarine (MA) for 28 d. Food intake (P < 0.05) and body weight gain (P < 0.05) were reduced in the animals fed the HMF diet compared with the other groups. In the fasting state, plasma LDL cholesterol was highest in animals fed the LMF diet, intermediary in those fed the MMF and MF diets, and lowest in those fed the HMF and MA diets (P< 0.05). Postprandially, the areas under the 0- to 3-h curves for the changes in plasma TG were lower in the HMF group than in the MA- and LMF-fed guinea pigs (P< 0.05). The fecal fat content was higher (P< 0.05) in the HMF group compared to the other milk fat groups. The present results suggest that modified milk fats can impact food intake, body weight gain, fasting cholesterolemia, and postprandial triglyceridemia, and these changes may be attributed to an altered fat absorption.
Asselin
Geneviève
G
Department of Food Science and Nutrition and Nutraceuticals and Functional Foods Institute, Laval University, Ste-Foy, Québec, Canada.
Lavigne
Charles
C
Bergeron
Nathalie
N
Angers
Paul
P
Belkacemi
Khaled
K
Arul
Joseph
J
Jacques
Hélène
H
D000818:Animals; D002784:Cholesterol / Q000032:analysis; D004032:Diet; D005215:Fasting / Q000378:metabolism*; D005223:Fats / Q000008:administration & dosage / Q000494:pharmacology*; D005227:Fatty Acids / Q000032:analysis; D005243:Feces / Q000737:chemistry; D006168:Guinea Pigs; D008055:Lipids / Q000032:analysis* / Q000097:blood; D008099:Liver / Q000737:chemistry; D008297:Male; D008892:Milk / Q000737:chemistry*; D019518:Postprandial Period; D015430:Weight Gain
D005223:Fats; D005227:Fatty Acids; D008055:Lipids; D002784:Cholesterol